- This event has passed.
Mayo Clinic Nephrology, Hypertension and Kidney Transplantation Update for the Clinician 2024
February 16, 2024 - February 19, 2024
$699
Note : This course offers Live (in-person) and Livestream (virtual) attendance options.
The Mayo Clinic Nephrology, Hypertension and Kidney Transplantation Update for the Clinician 2024 is a two-and-a-half-day symposium designed to update participants on a range of nephrology topics relevant to current medical practice. Through a combination of lectures, literature review, and case-based presentations, this symposium delivers up-to-date and cutting-edge information that can be directly integrated into clinical practice.
Course Highlights:
- Practical case-based discussions with a panel of experts in the field to increase the participants’ involvement in this course by using practical cases from the real world
- Onconephrology session
- Dedicated glomerulonephritis (GN) session day with internationally known experts in the field with state-of-the-art lectures
- Describe the role of sodium-glucose cotransporter-2 (SGLT2) inhibitors in specific patient population including those with diabetic nephropathy, chronic kidney disease, glomerulonephritis and post kidney transplantation
- Genetic testing in chronic kidney disease patients session
- Networking opportunities
- Abstract session
Target Audience
This course is intended for members of the nephrology community and will be of interest to nephrologists, nephrology trainees, nurse practitioners, physician assistants, internists, primary care physicians and other specialists who participate in the care of patients with kidney disorders and kidney and/or pancreas transplants.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Outline emerging therapies in lupus nephritis and IgA nephropathy.
- Identify innovative peritoneal dialysis approaches in the dialysis population.
- Recognize new biomarkers in diagnosing acute kidney injury.
- Examine the value of artificial intelligence in acute kidney injury.
- Describe how new cancer therapies including immunotherapies and CAR T-cell therapies can cause kidney injury.
- Discuss the role of emerging therapies in chronic kidney disease management.
Attendance at any Mayo Clinic course does not indicate or guarantee competence or proficiency in the skills, knowledge or performance of any care or procedure(s) which may be discussed or taught in this course.
For more information, visit the website
